The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Integrating mechanisms of pulmonary fibrosis
Open accessAbstract
Pulmonary fibrosis is a highly heterogeneous and lethal pathological process with limited therapeutic options. Although research on the pathogenesis of pulmonary fibrosis has frequently focused on the mechanisms that regulate the proliferation, activation, and differentiation of collagen-secreting myofibroblasts, recent studies have identified new pathogenic mechanisms that are critically involved in the initiation and progression of fibrosis in a variety of settings. A more detailed and integrated understanding of the cellular and molecular mechanisms of pulmonary fibrosis could help pave the way for effective therapeutics for this devastating and complex disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-17A has also been implicated in the pathogenesis of pulmonary fibrosis (Langrish et al., 2005; Bettelli et al., 2006; Simonian et al., 2009; Wilson et al., 2010).”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Self-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Self-citationIL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
Ortiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935
Fubini, B., & Hubbard, A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00149-7 · Cited by 935
The Nalp3 inflammasome is essential for the development of silicosis
Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., & Sutterwala, F. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803933105 · Cited by 907
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831
Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
Zhou, B., Comeau, M. R., Smedt, T. D., Liggitt, H. D., Dahl, M. E., Lewis, D. B., Gyarmati, D., Aye, T., Campbell, D. J., & Ziegler, S. F. (2005) · Nature Immunology · doi:10.1038/ni1247 · Cited by 819
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816
Self-citationMechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation
Zhu, Z., Zheng, T., Homer, R. J., Kim, Y.-K., Chen, N. Y., Cohn, L., Hamid, Q., & Elias, J. A. (2004) · Science · doi:10.1126/science.1095336 · Cited by 805
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Mitochondrial reactive oxygen species drive proinflammatory cytokine production
Naik, E., & Dixit, V. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110367 · Cited by 783
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
Self-citationAberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Bleomycins: towards better therapeutics
Chen, J., & Stubbe, J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1547 · Cited by 664
Methylation determines fibroblast activation and fibrogenesis in the kidney
Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M. (2010) · Nature Medicine · doi:10.1038/nm.2135 · Cited by 639
Zuo, F., Kaminski, N., Eugui, E., Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris, D., Kim, Y., DeLustro, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092134099 · Cited by 620
Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603
Self-citationThe radiotherapeutic injury – a complex ‘wound’
Denham, J. W., & Hauer-Jensen, M. (2002) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00060-9 · Cited by 596
Königshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O. V., Jahn, A., Rose, F., Fink, L., Seeger, W., Schaefer, L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33950 · Cited by 558
Siwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 507
Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M., Handley, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1698oc · Cited by 506
Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Gasse, P., Mary, C., Guenon, I., Noulin, N., Charron, S., Schnyder-Candrian, S., Schnyder, B., Akira, S., Quesniaux, V. F. J., Lagente, V., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32285 · Cited by 481
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A.-P., & Vassalli, P. (1990) · Nature · doi:10.1038/344245a0 · Cited by 454
Song, E., Ouyang, N., Hörbelt, M., Antus, B., Wang, M., & Exton, M. S. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1687 · Cited by 447
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Lee, C. G., Hartl, D., Lee, G. R., Koller, B., Matsuura, H., Da Silva, C. A., Sohn, M. H., Cohn, L., Homer, R. J., Kozhich, A. A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081271 · Cited by 434
Lappalainen, U., Whitsett, J. A., Wert, S. E., Tichelaar, J. W., & Bry, K. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0309oc · Cited by 430
Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Pétrilli, V., Tschopp, J., Lagente, V., Quesniaux, V. F. J., Ryffel, B., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1274oc · Cited by 410
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
Wynn, T. A., Cheever, A. W., Jankovic, D., Poindexter, R. W., Caspar, P., Lewis, F. A., & Sher, A. (1995) · Nature · doi:10.1038/376594a0 · Cited by 403
Self-citationKim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
Mortality in rheumatoid arthritis
Myllykangas-Luosuj→vi, R. A., Aho, K., & A. Isomäki, H. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80031-x · Cited by 384
Inhibition of airway remodeling in IL-5–deficient mice
Cho, J. Y., Miller, M., Baek, K. J., Han, J. W., Nayar, J., Lee, S. Y., McElwain, K., McElwain, S., Friedman, S., & Broide, D. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19133 · Cited by 377
Kim, Y. J., Hwang, S. J., Bae, Y. C., & Jung, J. S. (2009) · Stem Cells · doi:10.1002/stem.235 · Cited by 373
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
Moore, B. B., Paine, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A., & Toews, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4368 · Cited by 371
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
Miyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J. A., Piguet, P. F., & Vassalli, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118029 · Cited by 370
Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4333 · Cited by 363
Young, A., Koduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., Dixey, J., & on behalf of the Early Rheumatoid Arthritis Study (ERAS) group (2006) · Rheumatology · doi:10.1093/rheumatology/kel253 · Cited by 354
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 346
Rankin, J. A., Picarella, D. E., Geba, G. P., Temann, U. A., Prasad, B., DiCosmo, B., Tarallo, A., Stripp, B., Whitsett, J., & Flavell, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7821 · Cited by 344
Zhang, Y., Lee, T. C., Guillemin, B., Yu, M. C., & Rom, W. N. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.4188 · Cited by 334
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Prasse, A., Probst, C., Bargagli, E., Zissel, G., Toews, G. B., Flaherty, K. R., Olschewski, M., Rottoli, P., & Müller-Quernheim, J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1201oc · Cited by 328
Burgess, H. A., Daugherty, L. E., Thatcher, T. H., Lakatos, H. F., Ray, D. M., Redonnet, M., Phipps, R. P., & Sime, P. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00383.2004 · Cited by 317
The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Bringardner, B. D., Baran, C. P., Eubank, T. D., & Marsh, C. B. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1897 · Cited by 311
The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., & Toews, G. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0239oc · Cited by 309
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
Jiang, D., Liang, J., Hodge, J., Lu, B., Zhu, Z., Yu, S., Fan, J., Gao, Y., Yin, Z., Homer, R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci16861 · Cited by 303
Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
Kinder, B. W., Brown, K. K., Schwarz, M. I., Ix, J. H., Kervitsky, A., & King, T. E. (2008) · Chest · doi:10.1378/chest.07-1948 · Cited by 302
Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14136 · Cited by 299
Piguet, P., & Vesin, C. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07030515 · Cited by 288
Production of Interleukin 13 by Alveolar Macrophages from Normal and Fibrotic Lung
Hancock, A., Armstrong, L., Gama, R., & Millar, A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.1.2627 · Cited by 275
The role of CXC chemokines in pulmonary fibrosis
Strieter, R. M., Gomperts, B. N., & Keane, M. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30562 · Cited by 273
Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., & Pilling, D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107782 · Cited by 272
Chiaramonte, M. G., Mentink-Kane, M., Jacobson, B. A., Cheever, A. W., Whitters, M. J., Goad, M. E. P., Wong, A., Collins, M., Donaldson, D. D., Grusby, M. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020903 · Cited by 258
Self-citationCritical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Berlin, A., Ross, D. J., Kunkel, S. L., Charo, I. F., & Strieter, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12214 · Cited by 255
Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214136 · Cited by 248
γδ T cells protect against lung fibrosis via IL-22
Simonian, P. L., Wehrmann, F., Roark, C. L., Born, W. K., O'Brien, R. L., & Fontenot, A. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100061 · Cited by 242
Atabai, K., Jame, S., Azhar, N., Kuo, A., Lam, M., McKleroy, W., DeHart, G., Rahman, S., Xia, D. D., Melton, A. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40053 · Cited by 237
Dual Roles of IL-4 in Lung Injury and Fibrosis
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., & Phan, S. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2083 · Cited by 236
Thy-1 Promoter Hypermethylation: A Novel Epigenetic Pathogenic Mechanism in Pulmonary Fibrosis
Sanders, Y. Y., Pardo, A., Selman, M., Nuovo, G. J., Tollefsbol, T. O., Siegal, G. P., & Hagood, J. S. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0322oc · Cited by 235
Interaction of IL-13 and C10 in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis
Belperio, J. A., Dy, M., Burdick, M. D., Xue, Y. Y., Li, K., Elias, J. A., & Keane, M. P. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0009oc · Cited by 232
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Li, K., Ross, D. J., & Strieter, R. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1037 · Cited by 230
Hsu, E., Shi, H., Jordan, R. M., Lyons-Weiler, J., Pilewski, J. M., & Feghali-Bostwick, C. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30159 · Cited by 226
IL-33 Induces IL-13–Dependent Cutaneous Fibrosis
Rankin, A. L., Mumm, J. B., Murphy, E., Turner, S., Yu, N., McClanahan, T. K., Bourne, P. A., Pierce, R. H., Kastelein, R., & Pflanz, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903306 · Cited by 216
Chiaramonte, M. G., Schopf, L. R., Neben, T. Y., Cheever, A. W., Donaldson, D. D., & Wynn, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.920 · Cited by 214
Self-citationXia, H., Diebold, D., Nho, R., Perlman, D., Kleidon, J., Kahm, J., Avdulov, S., Peterson, M., Nerva, J., Bitterman, P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080001 · Cited by 213
Piguet, P. F., Ribaux, C., Karpuz, V., Grau, G. E., & Kapançi, Y. (1993) · PubMed · Cited by 212
Milam, J. E., Keshamouni, V. G., Phan, S. H., Hu, B., Gangireddy, S. R., Hogaboam, C. M., Standiford, T. J., Thannickal, V. J., & Reddy, R. C. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00333.2007 · Cited by 211
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Reiman, R. M., Thompson, R. W., Feng, C. G., Hari, D., Knight, R., Cheever, A. W., Rosenberg, H. F., & Wynn, T. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1471-1479.2006 · Cited by 206
Self-citationPPARs in Diseases: Control Mechanisms of Inflammation
Kostadinova, R., Wahli, W., & Michalik, L. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462905 · Cited by 198
Yang, G., Volk, A., Petley, T., Emmell, E., Giles-Komar, J., Shang, X., Li, J., Das, A. M., Shealy, D., Griswold, D. E., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2004.08.007 · Cited by 192
Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis
Simonian, P. L., Roark, C. L., Wehrmann, F., Lanham, A. K., Diaz del Valle, F., Born, W. K., O’Brien, R. L., & Fontenot, A. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.657 · Cited by 190
Oga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2066 · Cited by 190
Zhu, Z., Ma, B., Zheng, T., Homer, R. J., Lee, C. G., Charo, I. F., Noble, P., & Elias, J. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2953 · Cited by 188
Protection from Pulmonary Fibrosis in Leukotriene-Deficient Mice
PETERS-GOLDEN, M., BAILIE, M., MARSHALL, T., WILKE, C., PHAN, S. H., TOEWS, G. B., & MOORE, B. B. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.2104050 · Cited by 187
Kolodsick, J. E., Toews, G. B., Jakubzick, C., Hogaboam, C., Moore, T. A., McKenzie, A., Wilke, C. A., Chrisman, C. J., & Moore, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4068 · Cited by 185
Ramalingam, T. R., Pesce, J. T., Sheikh, F., Cheever, A. W., Mentink-Kane, M. M., Wilson, M. S., Stevens, S., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., et al. (2008) · Nature Immunology · doi:10.1038/ni1544 · Cited by 183
Self-citationBlackburn, M. R., Lee, C. G., Young, H. W. J., Zhu, Z., Chunn, J. L., Kang, M., Banerjee, S. K., & Elias, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16815 · Cited by 182
Park, G. Y., & Christman, J. W. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00513.2005 · Cited by 182
Crystal, R. G., Bitterman, P. B., Mossman, B., Schwarz, M. I., Sheppard, D., Almasy, L., Chapman, H. A., Friedman, S. L., King, T. E., Leinwand, L. A., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201069 · Cited by 181
Wilborn, J., Bailie, M., Coffey, M., Burdick, M., Strieter, R., & Peters-Golden, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118612 · Cited by 176
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2
Murray, L. A., Argentieri, R. L., Farrell, F. X., Bracht, M., Sheng, H., Whitaker, B., Beck, H., Tsui, P., Cochlin, K., Evanoff, H. L., et al. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.016 · Cited by 175
Kumar, R. K., Herbert, C., Yang, M., Koskinen, A. M. L., McKenzie, A. N. J., & Foster, P. S. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01420.x · Cited by 168
CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y. Y., Zisman, D. A., Belperio, J. A., & Strieter, R. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1164oc · Cited by 164
A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis
Nagase, T., Uozumi, N., Ishii, S., Kita, Y., Yamamoto, H., Ohga, E., Ouchi, Y., & Shimizu, T. (2002) · Nature Medicine · doi:10.1038/nm0502-480 · Cited by 163
Madala, S. K., Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Minnicozzi, S., Cheever, A. W., Thompson, R. W., Mentink-Kane, M. M., & Wynn, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903008 · Cited by 162
Self-citationInhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
Smith, R. E., Strieter, R. M., Phan, S. H., Lukacs, N. W., Huffnagle, G. B., Wilke, C. A., Burdick, M. D., Lincoln, P., Evanoff, H., & Kunkel, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4704 · Cited by 158
Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2on bleomycin-induced lung injury
Genovese, T., Cuzzocrea, S., Paola, R. D., Mazzon, E., Mastruzzo, C., Catalano, P., Sortino, M. A., Crimi, N., Caputi, A. P., Thiemermann, C., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00049704 · Cited by 156
Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis
Liu, R.-M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1903 · Cited by 153
Lupardus, P. J., Birnbaum, M. E., & García, K. C. (2010) · Structure · doi:10.1016/j.str.2010.01.003 · Cited by 151
Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., Stoolman, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38369 · Cited by 144
Selman, M., King, T. E., & Pardo, A. (2001) · Cited by 144
Wilson, M. S., Elnekave, E., Mentink-Kane, M. M., Hodges, M. G., Pesce, J. T., Ramalingam, T. R., Thompson, R. W., Kamanaka, M., Flavell, R. A., Keane-Myers, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31546 · Cited by 137
Self-citationA Rearranged Form of Epstein–Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
Kelly, B. G., Lok, S., Hasleton, P. S., Egan, J. J., & Stewart, J. P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2103058 · Cited by 135
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Gomperts, B. N., Xue, Y., Hong, K. M., Mestas, J., Ardehali, A. A., Mehrad, B., Saggar, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24233 · Cited by 128
Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis
Huaux, F., Liu, T., McGarry, B. M., Ullenbruch, M., Xing, Z., & Phan, S. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5470 · Cited by 114
Coward, W. R., Watts, K., Feghali‐Bostwick, C. A., Jenkins, G. R., & Pang, L. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01527-09 · Cited by 114
Ma, B., Zhu, Z., Homer, R., Gerard, C. J., Strieter, R. M., & Elias, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1872 · Cited by 111
Hasegawa, M., Fujimoto, M., Kikuchi, K., & Takehara, K. (1997) · PubMed · Cited by 109
Simonian, P. L., Roark, C. L., Wehrmann, F., Lanham, A. M., Born, W. K., O’Brien, R. L., & Fontenot, A. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900013 · Cited by 104
Pivotal Role of CCR1-Positive Leukocytes in Bleomycin- Induced Lung Fibrosis in Mice
Tokuda, A., Itakura, M., Onai, N., Kimura, H., Kuriyama, T., & Matsushima, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2745 · Cited by 103
Integrating the MicroRNome into the Study of Lung Disease
Nana-Sinkam, S. P., Hunter, M. G., Nuovo, G. J., Schmittgen, T. D., Gelinas, R. E., Galas, D. J., & Marsh, C. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1042pp · Cited by 101
Park, S., Ahn, M., Jang, H. K., Jang, A., Kim, D.-J., Koh, E.-S., Park, J., Uh, S., Kim, Y. H., Park, J. S., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.4.614 · Cited by 100
Decraene, A., Willems‐Widyastuti, A., Kasran, A., Boeck, K. D., Bullens, D. M. A., & Dupont, L. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-177 · Cited by 99
Lovgren, A. K., Kovacs, J. J., Xie, T., Potts, E. N., Li, Y., Foster, W. M., Liang, J., Meltzer, E. B., Jiang, D., Lefkowitz, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001564 · Cited by 90
IL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome
Keane, M. P., Gomperts, B. N., Weigt, S., Xue, Y., Burdick, M. D., Nakamura, H. K., Zisman, D. A., Ardehali, A. A., Saggar, R., Lynch, J. P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.511 · Cited by 88
IL-13 Receptor α2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung
Zheng, T., Liu, W., Oh, S.-Y., Zhu, Z., Hu, B., Homer, R., Cohn, L. E., Grusby, M. J., & Elias, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.522 · Cited by 87
Eosinophils and CCR3 Regulate Interleukin-13 Transgene-Induced Pulmonary Remodeling
Fulkerson, P. C., Fischetti, C. A., & Rothenberg, M. E. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060617 · Cited by 86
Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
Brodlie, M., McKean, M. C., Johnson, G. E., Anderson, A. E., Hilkens, C. M. U., Fisher, A. J., Corris, P. A., Lordan, J. L., & Ward, C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00067110 · Cited by 86
Cationic Amino Acid Transporter-2 Regulates Immunity by Modulating Arginase Activity
Thompson, R. W., Pesce, J. T., Ramalingam, T. R., Wilson, M. S., White, S., Cheever, A. W., Ricklefs, S., Porcella, S. F., Li, L., Ellies, L. G., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000023 · Cited by 85
Self-citationIngram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., & Bonner, J. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1492fje · Cited by 84
Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
Ramalingam, T. R., Pesce, J. T., Mentink‐Kane, M. M., Madala, S. K., Cheever, A. W., Comeau, M. R., Ziegler, S. F., & Wynn, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900181 · Cited by 64
Self-citationThe Antifibrogenic Potential of PPARγ Ligands in Pulmonary Fibrosis
Sime, P. J. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31816464e9 · Cited by 55
Obligatory Role for Interleukin-13 in Obstructive Lesion Development in Airway Allografts
Lama, V. N., Harada, H., Badri, L. N., Flint, A., Hogaboam, C. M., McKenzie, A. N. J., Martínez, F. J., Toews, G. B., Moore, B. B., & Pinsky, D. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050975 · Cited by 44
Genovese, T., Mazzon, E., Paola, R. D., Muià, C., Crisafulli, C., Caputi, A. P., & Cuzzocrea, S. (2005) · Shock · doi:10.1097/01.shk.0000190825.28783.a4 · Cited by 39
Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease
Wolff, D., Reichenberger, F., Steiner, B., et al. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703386 · Cited by 39
Huang, T. H.-W., Razmovski‐Naumovski, V., Kota, B. P., Lin, D. S.-H., & Roufogalis, B. D. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-102 · Cited by 38
Cited by
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Humphreys, B. D. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034227 · Cited by 1,231
Metadata
- Authors
- Wynn, T. A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-07-04
- Volume
- 208
- Issue
- 7
- Pages
- 1339-1350
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2090897026
- Cited by
- 1,274
- References
- 149
- FWCI
- 51.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.